Literature DB >> 15570421

Five-year evolution of a telangiectatic osteosarcoma initially managed as an aneurysmal bone cyst.

Tsuyoshi Saito1, Yoshinao Oda, Ken-Ichi Kawaguchi, Kazuhiro Tanaka, Shuichi Matsuda, Akio Sakamoto, Yukihide Iwamoto, Masazumi Tsuneyoshi.   

Abstract

We present the clinical, radiographic, and pathologic features of a telangiectatic osteosarcoma (TOS) of the right femoral neck in a 20-year-old man which was initially diagnosed and managed as an aneurysmal bone cyst (ABC). The lesion recurred twice. At the second recurrence TOS was diagnosed. The first local recurrence was recognized 4 years 8 months after the first operation. The clinical diagnosis for the recurrent lesion was recurrent ABC, and curettage and bone graft with internal fixation were performed. The second local recurrence was observed 8 months after the second surgery. The right lesser trochanter appeared destroyed on the radiograph, and a large medial soft tissue mass was demonstrated by computed tomography. The patient underwent wide resection of the tumor with prosthetic replacement of the right proximal femur. The histologic section for this lesion showed a blood-filled cystic lesion, and its wall contained sarcomatous cells with atypical mitoses and tumor osteoid. The histologic diagnosis for the second recurrent lesion was high-grade TOS. The retrospective review of the histologic section for the primary lesion showed similar features to ABC except for a few bizarre cells without mitosis in the tissue of cystic wall. The patient demonstrates no evidence of disease 13 months after the last surgery without adjuvant therapy (he declined chemotherapy).

Entities:  

Mesh:

Year:  2005        PMID: 15570421     DOI: 10.1007/s00256-004-0865-8

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  10 in total

Review 1.  Malignant transformation of aneurysmal bone cyst, with an analysis of the literature.

Authors:  M Kyriakos; D Hardy
Journal:  Cancer       Date:  1991-10-15       Impact factor: 6.860

2.  Aneurysmal bone cysts. A clinicopathologic study of 66 cases.

Authors:  J L Biesecker; R C Marcove; A G Huvos; V Miké
Journal:  Cancer       Date:  1970-09       Impact factor: 6.860

3.  Case report 111.

Authors:  C P Adler
Journal:  Skeletal Radiol       Date:  1980-02       Impact factor: 2.199

4.  Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.

Authors:  G Bacci; S Ferrari; P Ruggieri; R Biagini; N Fabbri; L Campanacci; P Bacchini; A Longhi; C Forni; F Bertoni
Journal:  Acta Orthop Scand       Date:  2001-04

5.  Aneurysmal bone cyst: evaluation of resection and of curettage in 20 cases.

Authors:  E V Koskinen; T I Visuri; T Holmström; M A Roukkula
Journal:  Clin Orthop Relat Res       Date:  1976 Jul-Aug       Impact factor: 4.176

6.  Telangiectatic osteogenic sarcoma: a clinicopathologic study of 124 patients.

Authors:  A G Huvos; G Rosen; S S Bretsky; A Butler
Journal:  Cancer       Date:  1982-04-15       Impact factor: 6.860

7.  Telangiectatic osteosarcoma.

Authors:  T R Mervak; K K Unni; D J Pritchard; R A McLeod
Journal:  Clin Orthop Relat Res       Date:  1991-09       Impact factor: 4.176

8.  Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor.

Authors:  Gaetano Bacci; Franco Bertoni; Alessandra Longhi; Stefano Ferrari; Cristiana Forni; Roberto Biagini; Patrizia Bacchini; Davide Donati; Marco Manfrini; Gabriella Bernini; Stefano Lari
Journal:  Cancer       Date:  2003-06-15       Impact factor: 6.860

9.  Telangiectatic osteogenic sarcoma.

Authors:  T Matsuno; K K Unni; R A McLeod; D C Dahlin
Journal:  Cancer       Date:  1976-12       Impact factor: 6.860

10.  Aneurysmal bone cyst. A review of 123 cases including primary lesions and those secondary to other bone pathology.

Authors:  V Martinez; H A Sissons
Journal:  Cancer       Date:  1988-06-01       Impact factor: 6.860

  10 in total
  8 in total

1.  Aneurysmal Bone Cyst: An Analysis of 38 Cases and Report of Four Unusual Surface Ones.

Authors:  Tina Shooshtarizadeh; Sajjadeh Movahedinia; Hassan Mostafavi; Khodamorad Jamshidi; Sam Hajialiloo Sami
Journal:  Arch Bone Jt Surg       Date:  2016-04

2.  Aneurysmal bone cyst of the metatarsal: A case report.

Authors:  Jiangyinzi Shang; Runsheng Guo; Ping Zhan; Chuwen Chen; Jing Kan; Hucheng Liu; Min Dai
Journal:  Oncol Lett       Date:  2016-08-12       Impact factor: 2.967

3.  Challenges in management of benign bone tumours complicated by pathological fracture in paediatric population.

Authors:  Yasir Salam Siddiqui; Mazhar Abbas; Julfiqar Muhammad; Mohd Khalid A Sherwani; Mohammad Jesan Khan; Akash Yadav
Journal:  Int J Burns Trauma       Date:  2021-06-15

Review 4.  [Differential diagnosis of intramedullary osteosarcomas].

Authors:  K Hauptmann; I Melcher; K-D Schaser
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

5.  [Secondary telangiectatic osteosarcoma of the left femur. A case presentation of an unusual course of disease].

Authors:  D Zajonz; M Werner; S Panzert; A S Strübing; S Tiepolt; E Fabsits; P Brandmaier; C-E Heyde; T Prietzel
Journal:  Orthopade       Date:  2014-05       Impact factor: 1.087

6.  Diaphyseal aneurysmal bone cysts (ABCs) of long bones in extremities: Analysis of surgical management and comparison with metaphyseal lesions.

Authors:  Pankaj Kumar Sharma; Zile Singh Kundu; Akshay Lamba; Sunita Singh
Journal:  J Clin Orthop Trauma       Date:  2021-04-17

7.  Telangiectatic osteosarcoma: a review of literature.

Authors:  Jun-Jian Liu; Shen Liu; Jian-Guang Wang; Wei Zhu; Ying-Qi Hua; Wei Sun; Zheng-Dong Cai
Journal:  Onco Targets Ther       Date:  2013-05-28       Impact factor: 4.147

8.  Diagnosing and discriminating between primary and secondary aneurysmal bone cysts.

Authors:  Hiromi Sasaki; Satoshi Nagano; Hirofumi Shimada; Masahiro Yokouchi; Takao Setoguchi; Yasuhiro Ishidou; Osamu Kunigou; Kosuke Maehara; Setsuro Komiya
Journal:  Oncol Lett       Date:  2017-02-07       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.